Skip to main content
. 2017 Sep 1;178:318–339. doi: 10.1016/j.drugalcdep.2017.05.028

Table 4.

Random effects moderator analysis results for PNS.

Moderator k1 Effect Size (d)2 95% CI Z Value P value Q betweeen (df)3 P of Q between
Drug targeted for intervention 6.43 (4) 0.17
Cocaine 4 0.4 0.13–0.67 2.89 <0.01
Opiates 3 0.18 −0.11–0.46 1.23 0.22
Opiates and cocaine 2 0.43 0.18–0.67 3.42 <0.01
Tobacco 2 1.02 0.37–1.67 3.09 <0.01
Poly substance 1 0.49 0.23–0.74 3.74 <0.001



Study decade 1.10 (2) 0.58
1990–1999 2 0.51 0.25–0.77 3.83 <0.001
2000–2009 3 0.30 0.01–0.59 2.01 0.05
2010 onwards 7 0.40 0.20–0.60 3.93 <0.001



Study Quality 0.36 (2) 0.84
Stong 1 0.48 0.21–0.75 3.43 <0.01
Moderate 5 0.36 0.06–0.66 2.32 0.02
Weak 6 0.44 0.30–0.58 0 <0.001



Itntervention Duration 0.32 (2) 0.85
<12 Weeks 5 0.47 0.28–0.67 4.73 <0.001
12 Weeks 2 0.42 0.18–0.67 3.35 0.04
>12 Weeks 5 0.37 0.02–0.71 2.06 <0.01



Reinforcer type 0.41 (1) 0.52
Monetary Vouchers 9 0.39 0.23–0.54 4.82 <0.001
Other' 3 0.51 0.17–0.85 2.94 <0.01



Opiate treatment 0.35 (1) 0.55
Methadone 8 0.45 0.30–0.60 6.00 <0.001
Other 4 0.32 −0.08–0.72 1.58 0.12

1Number of studies, 2Weighted random effects, 3A significant value of Q-between indicates significant differences among effect sizes between the categories of the moderator variable.